We are live on ! Find out more
REUN

Reunion Neuroscience Inc. Common Shares

Delisted

REUN was delisted on the 31st of July, 2023.

0 hedge funds and large institutions have $0 invested in Reunion Neuroscience Inc. Common Shares in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 210 (-21)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $1.94M → $0 (-$1.94M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
Holders Change
-21
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
21
Calls
Puts
Net Calls
Net Calls Change

REUN Hedge Fund Activity: Q3 2023 in Review

0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q3 2023, worth a combined $0 — down 100% from $1.94M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of REUN and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Beryl Capital Management, exiting entirely with an estimated $777K sold.

  • 0 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q3 2023, down from 21 in Q2 2023.
  • Funds reported $0 of Reunion Neuroscience Inc. Common Shares stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q3 2023 and 21 closed out, a net change of -21 holders.
  • The largest Reunion Neuroscience Inc. Common Shares seller in Q3 2023 was Beryl Capital Management, an estimated $777K sold.

Based on aggregated 13F filings for Q3 2023.